Joseph Knoll and his staff are credited with getting formulated selegiline. Even though selegeline's enhancement as a possible therapy for Parkinson's, Alzheimer's, and big depressive disorder was headed by other teams, Knoll remained with the forefront of research to the probable longevity maximizing effects of selegiline up right up until https://georgesq011lxt1.blognody.com/23649169/about-jnj-65355394